Literature DB >> 9528963

Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

O C Meijer1, E C de Lange, D D Breimer, A G de Boer, J O Workel, E R de Kloet.   

Abstract

Mice with a genetic disruption of the multiple drug resistance (mdr1a) gene were used to examine the effect of the absence of its drug-transporting P-glycoprotein product from the blood-brain barrier on the distribution and cell nuclear uptake of [3H]-dexamethasone in the brain. [3H]-dexamethasone (4 microg/kg mouse) was administered s.c. to adrenalectomized mdr1a (-/-) and mdr1a (+/+) mice. One hour later, the mice were decapitated, and the radioactivity was measured in homogenates of cerebellum, blood, and liver following extraction of the radioactive steroid. The frontal brain was cut in sections for autoradiography. In the cerebellum of the mdr1a mutants, the amount of [3H]-dexamethasone relative to blood was about 5-fold higher than observed in the controls, whereas the ratio in blood vs. liver was not different. Using autoradiography, it was found that brain areas expressing the glucocorticoid receptor (GR) in high abundance, such as the hippocampal cell fields and the paraventricular nucleus (PVN), showed a 10-fold increase in cell nuclear uptake of radiolabeled steroid. The amount of retained steroid increased toward levels observed in the pituitary, which contains a similar density of GRs. The [3H]-dexamethasone concentration in pituitary was not affected by mdr1a gene disruption. The GR messenger RNA expression pattern in hippocampus was not different between the wild types and mdr1a mutants, which rules out altered receptor expression as a cause of the enhanced dexamethasone uptake. In conclusion, the present study demonstrates that the brain is resistant to penetration by dexamethasone because of mdr1a activity at the level of the blood-brain barrier. The data support the concept of a pituitary site of action of dexamethasone in blockade of stress-induced ACTH release. Dexamethasone poorly substitutes for depletion of the endogenous glucocorticoid from the brain and therefore, in this tissue, may cause a condition resembling that of adrenalectomy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528963     DOI: 10.1210/endo.139.4.5917

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  71 in total

Review 1.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models.

Authors:  Stefan Lundquist; Mila Renftel; Julien Brillault; Laurence Fenart; Roméo Cecchelli; Marie-Pierre Dehouck
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

3.  Cortisol suppression and hearing thresholds in tinnitus after low-dose dexamethasone challenge.

Authors:  Veerle L Simoens; Sylvie Hébert
Journal:  BMC Ear Nose Throat Disord       Date:  2012-03-26

4.  Glucocorticoids exacerbate hypoxia-induced expression of the pro-apoptotic gene Bnip3 in the developing cortex.

Authors:  U S Sandau; R J Handa
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

5.  Distribution of suramin, an antitrypanosomal drug, across the blood-brain and blood-cerebrospinal fluid interfaces in wild-type and P-glycoprotein transporter-deficient mice.

Authors:  Lisa Sanderson; Adil Khan; Sarah Thomas
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

Review 6.  Steroids and injury to the developing brain: net harm or net benefit?

Authors:  Shadi N Malaeb; Barbara S Stonestreet
Journal:  Clin Perinatol       Date:  2014-03       Impact factor: 3.430

7.  Opposing influences of glucocorticoids and interleukin-1beta on the secretion of growth hormone and ACTH in the rat in vivo: role of hypothalamic annexin 1.

Authors:  J G Philip; C D John; P O Cover; J F Morris; H C Christian; R J Flower; J C Buckingham
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Maternal deprivation effect on the infant's neural stress markers is reversed by tactile stimulation and feeding but not by suppressing corticosterone.

Authors:  H J van Oers; E R de Kloet; T Whelan; S Levine
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  P-Glycoprotein Activity in Steroid-Responsive vs. Steroid-Resistant Nephrotic Syndrome.

Authors:  Hassan S Badr; Mahmoud A El-Hawy; Mohammed A Helwa
Journal:  Indian J Pediatr       Date:  2016-05-19       Impact factor: 1.967

Review 10.  Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy.

Authors:  Sherice Williams; Chaitali Ghosh
Journal:  Drug Discov Today       Date:  2019-09-18       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.